NeoTRIPaPDL1 Michelangelo: Neoadjuvant Chemotherapy ± Atezolizumab in Early, High-Risk and Locally Advanced TNBC

December 10-14, 2019; San Antonio, Texas
No significant increase in pCR rate with addition of atezolizumab to carboplatin/nab-paclitaxel in women with early, high-risk and locally advanced TNBC.
Format: Microsoft PowerPoint (.ppt)
File Size: 220 KB
Released: December 19, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Daiichi Sankyo, Inc.
Genentech
Merck Sharp & Dohme Corp
Puma Biotechnology
Seattle Genetics

Related Content

From Clinical Care Options (CCO), video featuring expert insights on best practices for nurses within a multidisciplinary CAR T-cell therapy care team

person default Caron A. Jacobson, MD
Program Director
Alix Beaupierre, BSN, RN, OCN person default Kathleen McDermott, RN, BSN, OCN, BMTCN
Registered Nurses: 2.0 Nursing contact hours Released: July 8, 2020 Expired: July 7, 2021

A short slideset from Clinical Care Options covering key clinical insights for the current management of HER2-positive early and metastatic breast cancer.

Neelima Denduluri, MD, FASCO Lee Schwartzberg, MD, FACP Released: July 8, 2020

Gain key clinical insights fast, with this short slideset from CCO on the optimal use of immune checkpoint inhibitors for RCC

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: July 7, 2020

Gain key clinical insights fast, with this short slideset from CCO on treatment options for patients with urothelial cancer

Daniel P. Petrylak, MD
Program Director
Matthew I. Milowsky, MD Jonathan E. Rosenberg, MD
Released: July 7, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?